| __timestamp | Amicus Therapeutics, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 381287000 |
| Thursday, January 1, 2015 | 47269000 | 452612000 |
| Friday, January 1, 2016 | 71151000 | 316800000 |
| Sunday, January 1, 2017 | 88671000 | 330100000 |
| Monday, January 1, 2018 | 127200000 | 265800000 |
| Tuesday, January 1, 2019 | 169861000 | 336200000 |
| Wednesday, January 1, 2020 | 156407000 | 423900000 |
| Friday, January 1, 2021 | 192710000 | 467000000 |
| Saturday, January 1, 2022 | 213041000 | 487000000 |
| Sunday, January 1, 2023 | 275270000 | 477100000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. United Therapeutics Corporation and Amicus Therapeutics, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, United Therapeutics consistently maintained higher SG&A expenses, peaking at approximately $487 million in 2022. In contrast, Amicus Therapeutics started with a modest $21 million in 2014, growing to $275 million by 2023. This represents a staggering 13-fold increase, highlighting their aggressive expansion strategy. Despite United Therapeutics' higher absolute expenses, their growth rate was more stable, with a 28% increase over the same period. This data provides a fascinating insight into how these companies balance growth and cost management, offering valuable lessons for investors and industry analysts alike.
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
GSK plc vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
United Therapeutics Corporation vs Xencor, Inc.: SG&A Expense Trends
Bausch Health Companies Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Viridian Therapeutics, Inc.